Quad Partnership on Track to Produce 1 Billion Covid-19 Jabs in India: POTUS
New Delhi: The US President Joe Biden on Wednesday expressed concerns about covid-19 and the production of Covid-19 vaccines. Before the Quad meeting, Joe Biden said that “Nothing is more urgent than working together to defeat COVID-19 so the world is much better prepared for future pandemics. The Quad partnership is on track to produce at least a billion vaccine doses in India by 2022,”
At the Global Summit to End the Covid-19, the US President said that “The US and its international partners are working to produce covid-19 vaccines in other countries,”
President Biden further added that “For example, our Quad partnership with India, Japan, and Australia is on track to help produce at least 1 billion vaccine doses in India to boost the global supply by the end of 2022. And we’re providing financing and helping strengthen manufacturing in South Africa, and produce more than 500 million doses of J&J in Africa for Africa next year,”
President Biden made a historic announcement to help the poor countries, in which he said that “Today, I’m announcing another historic commitment. The United States is buying another half-billion dose of Pfizer to donate to low and middle-income countries around the world. This is another half-billion dose that will all be shipped by this time next year, and it brings our total commitment to a donation, of donated vaccines, to over 1.1 billion vaccines to be donated,”
According to a media report, The US has already shipped nearly 160 million doses to 100 countries, more than every other country has donated combined. America’s donations of half a billion Pfizer vaccines through COVAX that Joe Biden announced before the G-7 summit in June.
According to the International politics experts, During the Quad meeting – China should be the main agenda to discuss. In a pandemic period and other issues – focus removed from China. The Leaders of Quad should not forget that the Quad group is specially designed to counter illegal activities of China.
(_Vinayak.Barot)
